BAP1, Wilms' tumor 1, and calretinin in predicting survival and response to first-line chemotherapy in patients with pleural mesothelioma.
Journal Information
Full Title: J Cancer Res Clin Oncol
Abbreviation: J Cancer Res Clin Oncol
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:
"Declarations Conflict of interestThe authors declared that they have no competing interest. Conflict of interest The authors declared that they have no competing interest."
Funding Disclosure
Evidence found in paper:
"Funding The project was supported by BAP1 stainings funded by the Meso-Lung study (Approval no 2012/168/REKnord)."
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025